Next Article in Journal
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
Next Article in Special Issue
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study
Previous Article in Journal
Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration
Previous Article in Special Issue
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways
 
 
Review

Article Versions Notes

Cancers 2022, 14(16), 4032; https://doi.org/10.3390/cancers14164032
Action Date Notes Link
article pdf uploaded. 20 August 2022 13:52 CEST Version of Record https://www.mdpi.com/2072-6694/14/16/4032/pdf-vor
article xml file uploaded 23 August 2022 10:08 CEST Original file -
article xml uploaded. 23 August 2022 10:08 CEST Update -
article pdf uploaded. 23 August 2022 10:08 CEST Updated version of record https://www.mdpi.com/2072-6694/14/16/4032/pdf-vor
article html file updated 23 August 2022 10:38 CEST Original file -
article xml file uploaded 24 August 2022 03:32 CEST Update -
article xml uploaded. 24 August 2022 03:32 CEST Update https://www.mdpi.com/2072-6694/14/16/4032/xml
article pdf uploaded. 24 August 2022 03:32 CEST Updated version of record https://www.mdpi.com/2072-6694/14/16/4032/pdf
article html file updated 24 August 2022 03:34 CEST Update -
article html file updated 24 August 2022 04:52 CEST Update -
article html file updated 24 August 2022 21:08 CEST Update https://www.mdpi.com/2072-6694/14/16/4032/html
Back to TopTop